Interferon-β Intensifies Interleukin-23-Driven Pathogenicity of T Helper Cells in Neuroinflammatory Disease.
Interferon-β Intensifies Interleukin-23-Driven Pathogenicity of T Helper Cells in Neuroinflammatory Disease.
复制标题
β干扰素增强了神经炎症性疾病中白细胞介素 - 23驱动的辅助性T细胞的致病性。
DOI:
10.3390/cells10082139
复制
发表时间:
2021-08-20
期刊:
影响因子:
6
通讯作者:
Axtell RC
中科院分区:
文献类型:
--
作者:
Agasing A;Quinn JL;Kumar G;Axtell RC
Interferon (IFN)-β is a popular therapy for multiple sclerosis (MS). However, 25–40% of patients are nonresponsive to this therapy, and it worsens neuromyelitis optica (NMO), another neuroinflammatory disease. We previously identified, in both NMO patients and in mice, that IFN-β treatment had inflammatory effects in T Helper (TH) 17-induced disease through the production of the inflammatory cytokine IL-6. However, other studies have shown that IFN-β inhibits the differentiation and function of TH17 cells. In this manuscript, we identified that IFN-β had differential effects on discrete stages of TH17 development. During early TH17 development, IFN-β inhibits IL-17 production. Conversely, during late TH17 differentiation, IFN-β synergizes with IL-23 to promote a pathogenic T cell that has both TH1 and TH17 characteristics and expresses elevated levels of the potent inflammatory cytokines IL-6 and GM-CSF and the transcription factor BLIMP. Together, these findings help resolve a paradox surrounding IFN-β and TH17-induced disease and illuminate the pathways responsible for the pathophysiology of NMO and MS patients who are IFN-β nonresponders.
登录
查看更多内容
影响因子:
3.7
作者:
Matsushita T;Tateishi T;Isobe N;Yonekawa T;Yamasaki R;Matsuse D;Murai H;Kira J
通讯作者:
Kira J
影响因子:
64.5
作者:
Ivanov, Ivaylo I.;McKenzie, Brent S.;Littman, Dan R.
通讯作者:
Littman, Dan R.
影响因子:
32.4
作者:
Veldhoen, M;Hocking, RJ;Stockinger, B
通讯作者:
Stockinger, B
影响因子:
29
作者:
Hartung, Hans-Peter;Steinman, Lawrence;Pohl, Christopher
通讯作者:
Pohl, Christopher
影响因子:
4.4
作者:
Tanabe, Y;Nishibori, T;David, M
通讯作者:
David, M